跳至主要内容
临床试验/NCT05025345
NCT05025345已完成不适用

Clinical Evaluation of the Vision Performance of TECNIS EYHANCE™ Intraocular Lenses With TECNIS SIMPLICITY™ as Compared to TECNIS® 1-piece Intraocular Lenses

Johnson & Johnson Surgical Vision, Inc.30 个研究点 分布在 1 个国家目标入组 228 人开始时间: 2021年9月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
228
试验地点
30
主要终点
MONOCULAR BEST-CORRECTED DISTANCE VISUAL ACUITY (BCDVA)

研究概览

简要总结

This study is a 6-month, prospective, multicenter, bilateral, randomized subject- and evaluator-masked, clinical investigation of the TECNIS Eyhance IOL versus the TECNIS 1-piece IOL.

The study will be conducted at up to 15 sites in the U.S.A and will enroll approximately 220 subjects to achieve approximately 200 randomized and bilaterally implanted subjects, resulting in approximately 100 evaluable subjects in each lens group at 6 months. Subjects are to be implanted with the same IOL in both eyes: TECNIS Eyhance IOL or the TECNIS 1-Piece IOL. The eye implanted first will be considered the primary study eye.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Minimum 22 years of age
  • Bilateral cataracts for which posterior chamber IOL implantation has been planned
  • Preoperative best corrected distance visual acuity (BCDVA) of 20/40 Snellen or worse with or without a glare source
  • Potential for postoperative best corrected visual acuity of 20/30 Snellen or better
  • Corneal astigmatism parameters:
  • Normal corneal topography and no irregular corneal astigmatism
  • Postoperative astigmatism can be surgically managed to be less than 1 D in each eye
  • Clear intraocular media other than cataract in each eye
  • Availability, willingness, ability, and sufficient cognitive awareness to comply with examination procedures and study visits
  • Signed informed consent and HIPAA authorization or equivalent documentation necessary to comply with applicable privacy laws pertaining to medical treatment in the governing countries
  • Ability to understand and respond to a questionnaire in English

排除标准

  • Any conditions or circumstances, including those specified in the TECNIS Eyhance™ IOL Directions for Use, that, in the opinion of the investigator, may increase risk over benefit or result in an adverse event during the study.
  • Inability to focus or fixate for prolonged periods of time (e.g., due to strabismus, nystagmus, etc.)
  • Concurrent participation or participation within 60 days prior to preoperative visit in any other clinical trial
  • Desire for monovision correction

结局指标

主要结局

MONOCULAR BEST-CORRECTED DISTANCE VISUAL ACUITY (BCDVA)

时间窗: 6 months

the mean monocular difference in Best-Corrected Distance Visual Acuity for the first eye between lens groups

次要结局

  • MONOCULAR DISTANCE-CORRECTED INTERMEDIATE VISUAL ACUITY AT 66 CM (DCVA66)(6 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (30)

Loading locations...

相似试验